Published: September 13, 2008
Discoverers of Small Regulatory RNAs and Cholesterol-Lowering Drugs to Receive Lasker Awards for Medical Research
NEW YORK, Sept. 13 /PRNewswire/ -- The 2008 Albert Lasker Medical Research
Awards (http://www.laskerfoundation.org) were announced today. First presented
in 1946, the Lasker Awards are the nation's most distinguished honor for
outstanding basic and clinical medical research discoveries and for lifetime
contributions to medical science.
The Lasker Award for Basic Medical Research honors Victor R. Ambros, 54,
of the University of Massachusetts Medical School,Worcester, David C.
Baulcombe, 56, of the University of Cambridge, and Gary B. Ruvkun, 56, of
Massachusetts General Hospital,Boston and Harvard Medical School, who
discovered tiny RNAs that regulate gene function. These RNAs, some of which
are known as microRNAs, govern a multitude of activities in animals and
plants, and they have been implicated in a wide range of diseases.
The Lasker-DeBakey Award for Clinical Medical Research honors Akira Endo,
74, of Biopharm Research Laboratories, Inc.,Tokyo, who discovered the first
statin. Statins significantly lower LDL-cholesterol quantities in the blood,
thus dramatically reducing the risk of coronary heart disease, a leading cause
of death worldwide and the number one killer in the U.S. Statins are now the
most widely prescribed medications inthe United States, and benefit an
estimated 30 million people worldwide.
The Lasker-Koshland Award for Special Achievement in Medical Science,
awarded biennially, honors Stanley Falkow, 74, of the Stanford University
School of Medicine, for his many contributions to our knowledge of
disease-causing microbes. Falkow's discoveries have shed light on how bacteria
transmit antibiotic resistance and other traits to one another and revealed
the means by which they infect animal hosts and elicit illness. He pioneered
the field of molecular pathogenesis of infectious disease and trained an
impressive number of leading investigators in this discipline.
The Awards will be presented at a luncheon ceremony on Friday, September
26th at the Pierre Hotel inNew York City. The Honorable Michael Bloomberg,
Mayor of theCity of New York, will be the keynote speaker.
Dr. Joseph L. Goldstein, recipient of the 1985 Lasker Award for Basic
Medical Research and the Nobel Prize in Medicine in 1985, chairs the 24-member
international scientific jury that selects recipients of the Lasker Awards. He
said that "the 2008 Lasker Awards honor investigators whose open-minded
thinking and experimentation challenged conventional wisdom. Their work
launched new fields of scientific research that have fostered significant
advances in the medical arena."
The discovery of small regulatory ribonucleic acids (RNAs) by Victor
Ambros, David Baulcombe, and Gary Ruvkun broke open an entire new field. Until
that time, proteins, not RNAs, were thought to govern gene activity in animal
cells. "No one imagined that such tiny RNAs could perform useful tasks. In
fact, the notion that small RNAs could control gene expression was unheard
of," Goldstein said. "Now, laboratories all over the world study hundreds of
these RNAs." The tiny molecules control a vast number of genes in plants as
well as animals, and play roles in human health and disease, including cancer,
viral infections, and congestive heart failure.
Until Akira Endo, treatment for high LDL-cholesterol levels-the bad
cholesterol-left much to be desired, a situation that resulted in an
unacceptably high incidence of coronary heart disease and premature death.
Dietary interventions and the few available drugs worked poorly and the
medications came with unwanted side effects. Many scientists also worried that
reducing cholesterol might be dangerous because the molecule carries out
essential jobs in the cell. "Endo believed in the potential benefits of
cholesterol-lowering drugs and toiled day and night for two years to find a
compound, the first statin, with that effect," Goldstein said. "Statins have
prolonged countless lives and revolutionized the prevention and treatment of
coronary heart disease." Today, millions of people worldwide take statins to
lower their LDL-cholesterol levels safely and markedly reduce their risk of
heart attacks.
Early in his career, Falkow discerned that bacteria pass antibiotic
resistance among one another on circular pieces of DNA-a finding that paved
the way toward recombinant DNA technology. He then pioneered that new method
to probe the molecular mechanisms by which bacteria invade their hosts, elude
the immune system, and trigger disease. "Stanley Falkow has spent the last
five decades delving into the workings of disease-causing microbes," Goldstein
said. "A legend in his own time, Falkow is regarded as one of the greatest
microbe hunters ever and has trained more than 100 students, many of whom are
making their own extraordinary contributions to the field of bacterial
pathogenesis."
This year marks the first presentation of the newly renamed Lasker-DeBakey
and Lasker-Koshland Awards, honoring the late Michael DeBakey and Daniel
Koshland, Jr. "We are proud to link the Lasker name with the names of these
outstanding scientists and humanitarians, who dedicated their lives to medical
science and human health and were lifelong supporters of the Lasker Foundation
and the Lasker Awards," said Dr. Maria C. Freire, President of the Albert and
Mary Lasker Foundation.
The Lasker Awards are given by the Albert & Mary Lasker Foundation. Dr.
Freire said that she and the Board of Directors are delighted at the
recommendations of the Lasker Jury, and congratulates the winners of this
year's Awards. "They follow the tradition of prior laureates in their
innovative scientific and medical research for the betterment of people
worldwide."
The Albert and Mary Lasker Foundation
The Lasker Foundation fosters the prevention and treatment of disease and
disabilities by honoring excellence in basic and clinical science, educating
the public, and advocating for support of medical research. This year the
Lasker Awards carry an honorarium of $300,000 for each Award category. The
laureates will receive a citation highlighting their achievements and an
inscribed statuette of the Winged Victory of Samothrace, the Lasker
Foundation's traditional symbol representing humanity's victory over disease,
disability, and death.
Lasker Awards often presage future recognition by the Nobel committee, so
they have become popularly known as "America's Nobels." Seventy-five Lasker
laureates have received the Nobel Prize, including 27 in the last two decades.
Additional materials will be posted on Saturday, September 13th at
www.laskerfoundation.org and will include the full citations for each Award
category, plus photos and video of the Awardees.
SOURCE The Albert and Mary Lasker Foundation
Copyright © 2012, PRNewswire
Copyright © 2012, NewsBlaze,
Daily News